EIDX - エイドス・セラピュ―ティクス (Eidos Therapeutics Inc.)

EIDXのニュース

   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 3.2% Past Previous 52-Week High - Market Mover  2020/12/22 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 3.2% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 112.7% year-to-date, up 98.8% over the past 12 months, and up 427.9% over the past five years. This week, the Dow Jones Industrial Average rose 1.2%, and the S&P 500 rose 1.3%. Trading Activity Trading volume this week was 1.3% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.0% higher than its 20-day moving average, and 79.4% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -9.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 1.9% Past Previous 52-Week High - Market Mover  2020/12/21 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 1.9% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 108.6% year-to-date, up 95.0% over the past 12 months, and up 417.9% over the past five years. This week, the Dow Jones Industrial Average rose 0.5%, and the S&P 500 rose 1.2%. Trading Activity Trading volume this week was 50.4% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 19.6% higher than its 20-day moving average, and 76.3% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -12.8% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 0.4% Past Previous 52-Week High - Market Mover  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 0.4% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Trading volume this week was 24.5% lower than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Close the Week 12.0% Higher - Weekly Wrap  2020/12/18 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed the week 12.0% higher than it did at the end of last week. The stock is currently up 107.9% year-to-date, up 87.4% over the past 12 months, and up 416.0% over the past five years. This week, the Dow Jones Industrial Average rose 1.0%, and the S&P 500 rose 1.5%. Trading Activity Shares traded as high as $122.48 and as low as $109.24 this week. Shares closed 0.4% above its 52-week high and 2e+2% above its 52-week low. Trading volume this week was 38.4% lower than the 10-day average and 19.9% lower than the 30-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at 3.5% higher than its 5-day moving average, 19.8% higher than its 20-day moving average, and 75.1% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -23.5% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.
   Eidos Therapeutics Inc Shares Climb 4.8% Past Previous 52-Week High - Market Mover  2020/12/17 22:30:00 Kwhen Finance
Eidos Therapeutics Inc shares closed 4.8% higher than its previous 52 week high, giving the company a market cap of $4B. The stock is currently up 98.0% year-to-date, up 73.1% over the past 12 months, and up 391.4% over the past five years. This week, the Dow Jones Industrial Average rose 0.4%, and the S&P 500 rose 0.9%. Trading Activity Trading volume this week was 22.1% higher than the 20-day average. Beta, a measure of the stocks volatility relative to the overall market stands at 1.1. Technical Indicators The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought. MACD, a trend-following momentum indicator, indicates an upward trend. The stock closed below its Bollinger band, indicating it may be oversold. The stock closed at Infinity% higher than its 5-day moving average, 21.7% higher than its 20-day moving average, and 76.7% higher than its 90-day moving average. Market Comparative Performance The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis Per Group Comparative Performance The company's price-earnings ratio is the same as its average peer. The company's performance over the last 1 year lags its average peer by -34.7% This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2020 Kwhen Inc.

calendar